Literature DB >> 19181635

Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects.

B De Paepe1, J Smet, M Lammens, S Seneca, J-J Martin, J De Bleecker, L De Meirleir, W Lissens, R Van Coster.   

Abstract

BACKGROUND: Mitochondrial diseases display a heterogeneous spectrum of clinical phenotypes and therefore the identification of the underlying gene defect is often a difficult task. AIMS: To develop an immunohistochemical approach to stain skeletal muscle for the five multi-protein complexes that organise the oxidative phosphorylation (OXPHOS) in order to improve the diagnostic workup of mitochondrial defects.
METHODS: OXPHOS complexes were visualised in skeletal muscle tissue using antibodies directed against different subunits. The staining patterns of patients with heteroplasmic defects in mtDNA tRNA genes were compared with those of normal and disease controls.
RESULTS: Normal skeletal muscle displayed a checkerboard staining pattern for complexes I to V due to the higher mitochondrial content of slow muscle fibres versus fast fibres. In patients with tRNA defects, a much more heterogeneous staining pattern was observed for complex I (all six patients) and complex IV (4 of 6 patients): a mosaic staining pattern in which individual fibres displayed staining intensities that ranged from strong to negative. Ragged red fibres (RRFs) in patients with MERRF (myoclonic epilepsy and ragged red fibres) were all complex I and IV negative, while in patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) the majority of RRFs were complex I negative and complex IV positive.
CONCLUSION: Immunohistochemical detection of OXPHOS complexes could represent a valuable additional diagnostic tool for the evaluation of mitochondrial cytopathy. The technique helps to detect heteroplasmic mtDNA defects. Staining for complex I in particular was able to identify two tRNA patients that stayed undetected with routine histochemical evaluation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181635     DOI: 10.1136/jcp.2008.061267

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

Review 1.  Nanodevices in diagnostics.

Authors:  Ye Hu; Daniel H Fine; Ennio Tasciotti; Ali Bouamrani; Mauro Ferrari
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011 Jan-Feb

Review 2.  [Metabolic myopathies - an overview].

Authors:  M Lammens; B Schoser
Journal:  Pathologe       Date:  2009-09       Impact factor: 1.011

3.  A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis.

Authors:  Mariana C Rocha; John P Grady; Anne Grünewald; Amy Vincent; Philip F Dobson; Robert W Taylor; Doug M Turnbull; Karolina A Rygiel
Journal:  Sci Rep       Date:  2015-10-15       Impact factor: 4.379

4.  Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research.

Authors:  Yasutoshi Koga; Nataliya Povalko; Eisuke Inoue; Hidefumi Nakamura; Akiko Ishii; Yasuhiro Suzuki; Makoto Yoneda; Fumio Kanda; Masaya Kubota; Hisashi Okada; Katsunori Fujii
Journal:  J Neurol       Date:  2018-09-29       Impact factor: 4.849

5.  Pathological Features in Paediatric Patients with TK2 Deficiency.

Authors:  Cristina Jou; Andres Nascimento; Anna Codina; Julio Montoya; Ester López-Gallardo; Sonia Emperador; Eduardo Ruiz-Pesini; Raquel Montero; Daniel Natera-de Benito; Carlos I Ortez; Jesus Marquez; Maria V Zelaya; Alfonso Gutierrez-Mata; Carmen Badosa; Laura Carrera-García; Jesica Expósito-Escudero; Monica Roldán; Yolanda Camara; Ramon Marti; Isidre Ferrer; Cecilia Jimenez-Mallebrera; Rafael Artuch
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

6.  Screen for abnormal mitochondrial phenotypes in mouse embryonic stem cells identifies a model for succinyl-CoA ligase deficiency and mtDNA depletion.

Authors:  Taraka R Donti; Carmen Stromberger; Ming Ge; Karen W Eldin; William J Craigen; Brett H Graham
Journal:  Dis Model Mech       Date:  2013-11-21       Impact factor: 5.758

7.  Mitochondrial DNA deletions and depletion within paraspinal muscles.

Authors:  G R Campbell; A Reeve; I Ziabreva; T M Polvikoski; R W Taylor; R Reynolds; D M Turnbull; D J Mahad
Journal:  Neuropathol Appl Neurobiol       Date:  2013-06       Impact factor: 8.090

8.  Therapeutic management of stroke-like episodes varies from that of encephalitis.

Authors:  Josef Finsterer
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.